Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.

[1]  R. Sussman,et al.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[2]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[3]  N. Milman,et al.  HLA-G polymorphisms and HLA-G expression in sarcoidosis. , 2006, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[4]  M. Selman,et al.  Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. , 2012, American journal of respiratory and critical care medicine.

[5]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[6]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[7]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[8]  Moisés Selman,et al.  Idiopathic pulmonary fibrosis , 2011, The Lancet.

[9]  G. Raghu,et al.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[10]  Naftali Kaminski,et al.  A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. , 2015, American journal of respiratory cell and molecular biology.

[11]  H. Collard,et al.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[12]  M. Selman,et al.  Idiopathic pulmonary fi brosis , 2011 .

[13]  A. Katzenstein.  Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP , 2012, Modern Pathology.

[14]  Susan Murray,et al.  Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? , 2007, American journal of respiratory and critical care medicine.

[15]  Sharon Sanderson,et al.  Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. , 2010, American journal of respiratory and critical care medicine.

[16]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[17]  D. Schroeder,et al.  Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. , 2010, Chest.

[18]  M. Murphy,et al.  The importance of early diagnosis and treatment , 1997 .

[19]  O. Hilberg,et al.  Idiopathic Pulmonary Fibrosis - Diagnosis and Treatment , 2014 .

[20]  T. Pietras,et al.  The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[21]  Byung-Hoon Lee,et al.  Gene expression profiling in human lung fibroblast following cadmium exposure. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  Naftali Kaminski,et al.  Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. , 2006, American journal of respiratory and critical care medicine.

[23]  Frank Stahl,et al.  Transcriptome analysis using next-generation sequencing. , 2013, Current opinion in biotechnology.

[24]  A. Wells,et al.  Managing diagnostic procedures in idiopathic pulmonary fibrosis , 2013, European Respiratory Review.

[25]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[26]  Luca Richeldi,et al.  Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment , 2014, European Respiratory Review.

[27]  Susan Murray,et al.  Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? , 2004, American journal of respiratory and critical care medicine.

[28]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[29]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[30]  Ivana V. Yang,et al.  Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis , 2013, Thorax.

[31]  T. Maher,et al.  The treatment of idiopathic pulmonary fibrosis , 2014, F1000prime reports.

[32]  Naftali Kaminski,et al.  Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.

[33]  Johan A. K. Suykens,et al.  Least Squares Support Vector Machine Classifiers , 1999, Neural Processing Letters.

[34]  Zora Modrusan,et al.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis , 2014, Thorax.

[35]  Fatih Ozsolak,et al.  RNA sequencing: advances, challenges and opportunities , 2011, Nature Reviews Genetics.

[36]  R. Bois,et al.  Strategies for treating idiopathic pulmonary fibrosis , 2010, Nature Reviews Drug Discovery.

[37]  H. Collard,et al.  Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.

[38]  A. Wells.  The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF) - practical implications , 2013, Respiratory Research.

[39]  David P. Naidich,et al.  Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. , 2013, American journal of respiratory and critical care medicine.

[40]  Arnold Simanowitz,et al.  international consensus statement , 2000 .

[41]  N. Müller,et al.  Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. , 2008, American journal of respiratory and critical care medicine.

[42]  Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma , 2014, European Respiratory Journal.

[43]  M. Selman,et al.  TISSUE INHIBITOR OF METALLOPROTEINASE-3 IS UP-REGULATED BY TRANSFORMING GROWTH FACTOR-β1 IN VITRO AND EXPRESSED IN FIBROBLASTIC FOCI IN VIVO IN IDIOPATHIC PULMONARY FIBROSIS , 2006, Experimental lung research.